Revenio Oyj : Invitation to Revenio Group Corporation's audiocast and teleconference call
April 11, 2024 at 07:35 am
Share
English
Finnish
Published: 2024-04-11 08:30:00 CEST
Revenio Group Corporation
Investor News
Invitation to Revenio Group Corporation's audiocast and teleconference call
Revenio Group Corporation | Press Release | April 11, 2024 at 09:30:00 EEST
Revenio Group Corporation's January-March 2024 Interim report will be published on Thursday, April 25, 2024, approximately at 09.00 a.m. (EEST). The report will be available at www.reveniogroup.fi/en/investors/reports_and_presentations.
An audiocast and teleconference call for analysts and investors will be held in English at 3.00 p.m. (EEST) on the same day.
Audiocast: https://revenio.videosync.fi/q1-2024/
To ask questions, please join the teleconference by registering using the following link: https://palvelu.flik.fi/teleconference/?id=50048930
After the registration, you will be provided with a phone number, user ID and a conference ID to access the conference. To ask a question, please press #5 on your telephone keypad to enter the queue.
A recording of the audiocast will be published on www.reveniogroup.fi/en/ after the event.
For further information, please contact
Robin Pulkkinen, CFO, tel. +358 50 505 9932
robin.pulkkinen@revenio.fi
Distribution
Key media
www.reveniogroup.fi/en
Revenio Group in brief
Revenio is a global provider of comprehensive eye care diagnostic solutions. The group offers fast, user-friendly, and reliable tools for diagnosing glaucoma, diabetic retinopathy, and macular degeneration (AMD). Revenio's ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters as well as clinical software under the iCare brand.
In 2023, the Group's net sales totaled EUR 96.6 million, with an operating profit of EUR 26.3 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.
Attachments:
Invitation to Revenio Group Corporations audiocast and teleconference call.pdf
This news release was distributed by Company News System, www.nasdaqomxnordic.com/news/marketnotices
To subscribe on regulatory news from this company, go to the subscription page
Attachments
Original Link
Permalink
Disclaimer
Revenio Group Oyj published this content on
11 April 2024 and is solely responsible for the information contained therein. Distributed by
Public, unedited and unaltered, on
11 April 2024 06:34:02 UTC.
Revenio Group Oyj, formerly Done Solutions Oyj, is a Finland-based company primarily engaged in the health technology segment. The Companyâs activities are divided into two business areas: Revenio Health Tech, which is responsible for the design, manufacture and sale of tonometers and bone density measurement devices; as well as Revenio Technology and Services, which provides contact center services for material handling systems. It distributes products in a range of countries, including the United States, Canada, Australia, Japan and India. Furthermore, the Company is a parent of Done Medical Oy, Kauhajoen Sisalogistiikka Oy, Icare Finland Oy, Oscare Medical Oy and Midas Touch Oy, among others.